FAT1 and head and neck squamous cell carcinoma: Here, we provide evidence that inactivation mutations and genomic alterations in FAT1 results in YAP1 activation via inactivation of the Hippo signaling pathway, thereby contributing to the progression of HNSCC and likely multiple other human malignancies displaying unrestrained YAP1 function.